Not applicableStudy completedNCT06030232What this trial is testingTransarterial Radioembolization (TARE) in COlorectal MEtastasis of LiverWho this might be right forTransarterial Radioembolization Ankara University 202
Testing effectiveness (Phase 2)Looking for participantsNCT07145801What this trial is testingY-90 Treatment Response Using Transarterial RadioembolizationWho this might be right forHCCHepatocellular CarcinomaLiver Cancer+3 more Thomas Jefferson University 30
Testing effectiveness (Phase 2)Study completedNCT02936388What this trial is testingTransarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver MetastasisWho this might be right forUveal Melanoma Charite University, Berlin, Germany 108
Not applicableLooking for participantsNCT05953337What this trial is testingRadioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular CarcinomaHepatocellular Carcinoma Non-resectableLiver Cancer ABK Biomedical 120
Not applicableStudy completedNCT05643391What this trial is testingSafety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Erasme University Hospital 20
Not applicableLooking for participantsNCT06873269What this trial is testingHolmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular CarcinomaWho this might be right forLocally Advanced Hepatocellular CarcinomaLiver CirrhosisNon-metastatic Hepatocellular Carcinoma Universitair Ziekenhuis Brussel 100
Early research (Phase 1)Study completedNCT06310590What this trial is testingSafety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular CarcinomaWho this might be right forUnresectable Hepatocellular Carcinoma Chengdu New Radiomedicine Technology Co. LTD. 40
Not applicableLooking for participantsNCT07252323What this trial is testingA Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)Who this might be right forCarcinomaHepatocellular Carcinoma Yonsei University 48
Large-scale testing (Phase 3)Looking for participantsNCT07293468What this trial is testingComparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)Who this might be right forHepatocellular Carcinoma (HCC) Tuen Mun Hospital 106
Not applicableLooking for participantsNCT06862934What this trial is testingLiver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant TreatmentsWho this might be right forIntrahepatic Cholangiocarcinoma (Icc) Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Testing effectiveness (Phase 2)Study completedNCT00867750What this trial is testingSIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Sirtex Medical 28
Testing effectiveness (Phase 2)Looking for participantsNCT06860815What this trial is testingCemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Carcinoma in the Liver City of Hope Medical Center 11
Not applicableLooking for participantsNCT05953961What this trial is testing90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With HypoalbuminemiaWho this might be right forCarcinoma, Hepatocellular Ochsner Health System 50
Not applicableLooking for participantsNCT07315633What this trial is testingAn Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver CancerWho this might be right forHepatocellular Carcinoma (HCC)Liver Cancer, AdultLiver Cancer University Hospital, Ghent 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06040099What this trial is testingA US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TAREWho this might be right forHepatocellular Carcinoma (HCC) AstraZeneca 56
Not applicableEnded earlyNCT04702230What this trial is testingValue of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial RadioembolizationWho this might be right forLiver Neoplasm University of Zurich 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04777851What this trial is testingRegorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7Who this might be right forCarcinoma, Hepatocellular Translational Research in Oncology 496
Large-scale testing (Phase 3)Looking for participantsNCT06900543What this trial is testingChinese HCC Efficacy Evaluation, Response and Safety Study of TareSphereWho this might be right forUnresectable Hepatocellular Carcinoma Chengdu New Radiomedicine Technology Co. LTD. 108
Testing effectiveness (Phase 2)Study completedNCT04301778What this trial is testingDurvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic CholangiocarcinomaWho this might be right forUnresectable Intrahepatic Cholangiocarcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Post-approval studies (Phase 4)UnknownNCT02729506What this trial is testingTransarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma King Faisal Specialist Hospital & Research Center 150